Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s share price shot up 1% during mid-day trading on Tuesday . The company traded as high as $484.23 and last traded at $483.98. 219,293 shares were traded during mid-day trading, a decline of 85% from the average session volume of 1,508,839 shares. The stock had previously closed at $479.39.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Truist Financial boosted their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Evercore ISI reduced their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research report on Friday, July 19th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Robert W. Baird increased their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $446.45.
Intuitive Surgical Price Performance
The company has a 50 day moving average price of $459.60 and a 200-day moving average price of $419.17. The stock has a market capitalization of $171.65 billion, a PE ratio of 87.36, a PEG ratio of 5.20 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the previous year, the firm posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.
Insider Transactions at Intuitive Surgical
In related news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 51,717 shares of company stock valued at $24,743,576. Corporate insiders own 0.90% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
A number of institutional investors have recently modified their holdings of ISRG. One Wealth Management Investment & Advisory Services LLC boosted its stake in Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares in the last quarter. Indiana Trust & Investment Management CO lifted its stake in shares of Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after buying an additional 25 shares in the last quarter. Hoxton Planning & Management LLC grew its holdings in shares of Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares during the last quarter. First Affirmative Financial Network increased its position in shares of Intuitive Surgical by 2.7% during the second quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock valued at $443,000 after acquiring an additional 26 shares in the last quarter. Finally, Moors & Cabot Inc. raised its holdings in Intuitive Surgical by 2.3% in the 2nd quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock worth $516,000 after acquiring an additional 26 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.